UK markets closed

Novozymes A/S (0Q4U.IL)

IOB - IOB Delayed price. Currency in DKK
Add to watchlist
423.75-2.25 (-0.53%)
At close: 03:59PM BST
Currency in DKK

Valuation measures4

Market cap (intra-day) 197.35B
Enterprise value 203.93B
Trailing P/E 39.15
Forward P/E 35.09
PEG ratio (5-yr expected) 0.30
Price/sales (ttm)6.61
Price/book (mrq)14.15
Enterprise value/revenue 11.39
Enterprise value/EBITDA 37.27

Trading information

Stock price history

Beta (5Y monthly) 0.44
52-week change 321.16%
S&P500 52-week change 325.26%
52-week high 3440.00
52-week low 3274.90
50-day moving average 3402.95
200-day moving average 3355.17

Share statistics

Avg vol (3-month) 3465.69k
Avg vol (10-day) 3346.91k
Shares outstanding 5222.86M
Implied shares outstanding 6276.79M
Float 8194.75M
% held by insiders 18.01%
% held by institutions 140.46%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 410.2
Forward annual dividend yield 43.59%
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 41.45
Payout ratio 448.70%
Dividend date 3N/A
Ex-dividend date 411 Oct 2023
Last split factor 25:1
Last split date 328 Nov 2011

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Jun 2023

Profitability

Profit margin 19.31%
Operating margin (ttm)25.03%

Management effectiveness

Return on assets (ttm)10.14%
Return on equity (ttm)26.21%

Income statement

Revenue (ttm)17.74B
Revenue per share (ttm)64.12
Quarterly revenue growth (yoy)-1.60%
Gross profit (ttm)9.59B
EBITDA 5.63B
Net income avi to common (ttm)3.42B
Diluted EPS (ttm)12.32
Quarterly earnings growth (yoy)-25.10%

Balance sheet

Total cash (mrq)1.05B
Total cash per share (mrq)3.78
Total debt (mrq)8.13B
Total debt/equity (mrq)58.88%
Current ratio (mrq)1.37
Book value per share (mrq)48.32

Cash flow statement

Operating cash flow (ttm)3.25B
Levered free cash flow (ttm)1.02B